mesalamine has been researched along with Diverticular Diseases in 9 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Diverticular Diseases: Diseases of the DIVERTICULUM often due to infection and/or inflammation (DIVERTICULITIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Tursi, A | 3 |
| Cassieri, C | 1 |
| Colucci, R | 1 |
| Elisei, W | 2 |
| Picchio, M | 2 |
| Brandimarte, G | 2 |
| Flum, DR | 1 |
| Read, TE | 1 |
| Iannone, A | 1 |
| Ruospo, M | 1 |
| Wong, G | 1 |
| Barone, M | 1 |
| Principi, M | 1 |
| Di Leo, A | 1 |
| Strippoli, GFM | 1 |
| Koch, M | 1 |
| Festa, V | 1 |
| Chiesara, F | 1 |
| Moretti, A | 1 |
| Bianchi, M | 1 |
| Dezi, A | 1 |
| Campanini, A | 1 |
| De Conto, U | 1 |
| Cavasin, F | 1 |
| Bastiani, F | 1 |
| Camarotto, A | 1 |
| Gardini, L | 1 |
| Geremia, A | 1 |
| Marastoni, C | 1 |
| Missorini, C | 1 |
| Quarantelli, E | 1 |
| Sassi, U | 1 |
| Scarabello, F | 1 |
| Dal Bo, N | 1 |
| Riccò, M | 1 |
| Grillo, S | 1 |
| Landi, S | 1 |
| Di Mario, F | 2 |
| Scarpignato, C | 1 |
| Dai, C | 1 |
| Jiang, M | 1 |
| Sun, MJ | 1 |
| Cuomo, R | 1 |
| Cargiolli, M | 1 |
| Andreozzi, P | 1 |
| Zito, FP | 1 |
| Sarnelli, G | 1 |
3 reviews available for mesalamine and Diverticular Diseases
| Article | Year |
|---|---|
Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticular Diseases; Diverticulitis; Diverticulum, Colon; | 2018 |
[Diverticular disease: towards 2020. An evidence-based approach].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticular Diseases; Humans; Italy; Mesalamine; Retrospec | 2016 |
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dietary Fiber; Diverticular Diseases; Drug Therapy, Combina | 2017 |
6 other studies available for mesalamine and Diverticular Diseases
| Article | Year |
|---|---|
Budesonide MMX Is Effective in Patients Having Persistent Symptoms and Raised Fecal Calprotectin Following Treatments for Diverticular Disease.
Topics: Aged; Budesonide; Colonic Diseases; Diverticular Diseases; Drug Administration Schedule; Drug Therap | 2019 |
Evidence-Based Management of Diverticular Disease: What's New and What's Missing?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Decision-Making; Colorectal | 2020 |
A Primary-Care Interventional Model on the Diverticular Disease: Searching for the Optimal Therapeutic Schedule.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Anti-Inflammatory Agent | 2016 |
Current Management of Patients With Diverticulosis and Diverticular Disease: A Survey From the 2nd International Symposium on Diverticular Disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Colonoscopy; Congresses as Topic; Di | 2016 |
"Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease: Reply".
Topics: Colon; Diverticular Diseases; Diverticulitis; Humans; Mesalamine; Primary Prevention; Randomized Con | 2019 |
Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease.
Topics: Colon; Diverticular Diseases; Diverticulitis; Humans; Mesalamine; Primary Prevention; Randomized Con | 2019 |